Wuhan Vanz Pharm Inc.

 

Wuhan Vanz Pharm Inc., Your reliable supplier!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsActive Pharmaceutical Ingredient

Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1

Good quality Pharmaceutical Intermediates for sales
Good quality Pharmaceutical Intermediates for sales
I am very happy to cooperate with your company for nearly three years, thank you very attentive service, thank you for the excellent product quality.

—— Stephnie

You always have very fast delivery, very happy to cooperate with you. Thank you.

—— John

Very pleased to become your customer, and very happy for our cooperation, hope to be your long-term parter.

—— Sara

we received the package, very fast, the quality is very good, will continue to buy your products.

—— Luice

I have emailed you a couple times and they get returned as undeliverable. Yes. I am happy with the powders. thank you.

—— Bryan

I'm Online Chat Now

Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1

China Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1 supplier
Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1 supplier Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1 supplier

Large Image :  Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1

Product Details:

Place of Origin: China
Brand Name: vanz
Certification: ISO9001
Model Number: 15663-27-1

Payment & Shipping Terms:

Minimum Order Quantity: 1kg
Packaging Details: bags or drum
Delivery Time: 3-5 days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 200kg per month
Contact Now
Detailed Product Description
Name: Cisplatin CAS: 15663-27-1
Appearance: Yellow Crystal Powder COA: Available
Assay: 99%min Stock: Available

Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1
 
Introduction
Cisplatin is a chemotherapy agent. It was the first member of a class of platinum-containing anti-cancer drugs, which now also includes carboplatin and oxaliplatin. These platinum complexes react in the body, binding to DNA and causing the DNA strands to crosslink, which ultimately triggers cells to die in a programmed way.
Cisplatin was discovered in 1972. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.
 

Product NameCisplatin
Synonyms1-cyclobutanedicarboxylato(2-)-o,o’)-diammine((sp-4-2)-platinu
CAS NO.15663-27-1
EINECS15663-27-1
Molecular FormulaC6H12N2O4Pt
Molecular Weight371.25
Specifications:
StandardAssay ≥99%
AppearanceYellow crystalline powder
Test MethodHPLC
Other information:
Packing100G;500G;1Kg;25Kg(Export worthy packing)
ApplicationsAnticancer
StatusCommercials
RemarkFor more details,please contact us
 

 
Medical uses
 
Cisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid malignancies. It is used to treat various types of cancers, including sarcomas, some carcinomas (e.g., small cell lung cancer, squamous cell carcinoma of the head and neck and ovarian cancer), lymphomas, bladder cancer, cervical cancer,and germ cell tumors.
Cisplatin is particularly effective against testicular cancer; the cure rate was improved from 10% to 85%.
In addition, cisplatin is used in Auger therapy.
 
Side Effects
 
Cisplatin has a number of side-effects that can limit its use:

  • Nephrotoxicity (kidney damage) is a major concern. The dose is reduced when the patient's creatinine clearance (a measure of renal function) is reduced. Adequate hydration and diuresis is used to prevent renal damage. The nephrotoxicity of platinum-class drugs seems to be related to reactive oxygen species and in animal models can be ameliorated by free radical scavenging agents (e.g., amifostine). Nephrotoxicity is a dose-limiting side effect.
  • Neurotoxicity (nerve damage) can be anticipated by performing nerve conduction studies before and after treatment. Common neurological side effects of cisplatin include visual perception and hearing disorder, which can occur soon after treatment begins.
  • Nausea and vomiting: cisplatin is one of the most emetogenic chemotherapy agents, but this symptom is managed with prophylactic antiemetics (ondansetron, granisetron, etc.) in combination with corticosteroids. Aprepitant combined with ondansetron and dexamethasone has been shown to be better for highly emetogenic chemotherapy than just ondansetron and dexamethasone.
  • Ototoxicity (hearing loss): there is at present no effective treatment to prevent this side effect, which may be severe. Audiometric analysis may be necessary to assess the severity of ototoxicity. Other drugs (such as the aminoglycoside antibiotic class) may also cause ototoxicity, and the administration of this class of antibiotics in patients receiving cisplatin is generally avoided. The ototoxicity of both the aminoglycosides and cisplatin may be related to their ability to bind to melanin in the stria vascularis of the inner ear or the generation of reactive oxygen species.
  • Electrolyte disturbance: Cisplatin can cause hypomagnesaemia, hypokalaemia and hypocalcaemia. The hypocalcaemia seems to occur in those with low serum magnesium secondary to cisplatin, so it is not primarily due to the cisplatin.
  • Hemolytic anemia can be developed after several courses of cisplatin. It is suggested that an antibody reacting with a cisplatin-red-cell membrane is responsible for hemolysis.

Yellow Crystal Powder Cisplatin Active Pharmaceutical Ingredient CAS 15663-27-1
Related Products

CAS# 1499193-67-7(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H
-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane hydrochloride (1:4)
CAS# 1441670-89-8(S)-tert-butyl 6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]
heptane-
CAS# 1256387-87-7(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol
-2-yl)-2
CAS# 1256388-51-8Ledipasvir
CAS# 33069-62-4Paclitaxel Intermediate; 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete benzenepropanoic
acid deriv.; Taxal; Taxol A
CAS# 148408-66-6Docetaxel trihydrate
CAS# 183133-96-2Cabazitaxel intermediate
CAS# 52787-14-14-METHOXYCARBONYLMETHYL-BENZOIC ACID METHYL ESTER
CAS# 61-33-6Benzylpenicillin; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
CAS# 20439-47-8

(1R,2R)-(-)-1,2-Diaminocyclohexane; (R,R)-DACH

 
FAQ
 
Q1: Are you a manufacturer ?
A: Yes, We manufacture bulk products in our factory located in Jiayu, Hubei, and produce small quantity and customer synthesis products in our lab located in Wuhan. But we also do some trading business.
Q2: What`s your delivery
A: We send goods in 3 working day after receiving your payment by DHL, FEDEX, TNT, EMS, AIR OR SEA as you request, usually you can find shipping details in 3 to 5 working days after your payment.
Q3: What certificates and documents do you offer?
A: Some technical paperwork is available, such as COA, HNMR, HPLC, LC-MS etc.
Q4: Why should I choose you?
A: Factory supply with the most compatitive price and high quality!!!
Q5: Can I get best price from you?
A: Of course. We don't chase excessive profits and always try tp give best offer. If you are good at bargaining, you can also enjoy fun of bargaining. Just don't make it too hard!
Q6: How should I pay?
A: We accept all kinds of payment ways. such as alibaba trade asssurance, T/T, West Union, Money Gram.
Q7: Do you provide free sample?
A: We can provide free sample of some chemicals and you just need you to cover the delivery cost.
 
 

Contact Details
Wuhan Vanz Pharm Inc.

Contact Person: Amy

Tel: +8613277095342

Send your inquiry directly to us (0 / 3000)